In this context, chemical compounds stabilizing R-loops in cancer backgrounds where the BIR pathway is intact may reveal a good strategy to enhance the potency of gene-specific genotoxic chemotherapeutic drugs such as Topoisomerase II poisons. The gene discussed is KCNJ11; the disease is cancer.